Soleno Therapeutics Inc (SLNO) — Cash Flow Reinvestment Rate
Soleno Therapeutics Inc (SLNO) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $40.00K (capex $40.00K ) from operating cash flow of $25.98 Million. See SLNO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Soleno Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Soleno Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Soleno Therapeutics Inc.
Annual Cash Flow Reinvestment Rate for Soleno Therapeutics Inc (2025–2025)
Year-by-year capital reinvestment analysis for Soleno Therapeutics Inc. See how financially flexible is Soleno Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.31x | $201.78 Million | $46.80 Million | $73.00K | — |